Methocarbamol Tablet, Film Coated
Product Images NDC 67296-2193

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methocarbamol (NDC 67296-2193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (500 mg (100 Tablets Bottle))

Package Label-principal Display Panel (500 mg (100 Tablets Bottle))
Label for Methocarbamol Tablets USP 500 mg film-coated tablets. The label indicates a count of 100 tablets, distributed by Aurobindo Pharma USA, Inc., and includes storage instructions and barcode. The manufacturer is noted as made in India. This is a prescription oral tablet product.*
FDA Label Image

Package Label-principal Display Panel (750 mg (100 Tablets Bottle))

Package Label-principal Display Panel (750 mg (100 Tablets Bottle))
Label for Methocarbamol Tablets USP 750 mg, film-coated tablets by Aurobindo Pharma USA, Inc. The label indicates each film-coated tablet contains 750 mg Methocarbamol and the package contains 100 tablets. It includes storage instructions and distributor information for Aurobindo Pharma USA, Inc., located in East Windsor, NJ, with manufacturing noted as Made in India.*
FDA Label Image

Chemical Structure (Methocarbamol Str)

Chemical Structure (Methocarbamol Str)
Chemical structure of Methocarbamol, depicting its molecular arrangement including hydroxyl (OH), amide (NH2), methoxy (OCH3) groups, and aromatic ring present in the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.